[Interpretation of connotation of Yuebi Plus Banxia Decoction based on severe cases and modern pathophysiological mechanisms and experience of treating severe pulmonary infection, acute exacerbation of chronic obstructive pulmonary disease, and respiratory failure with this decoction]
- PMID: 39701719
- DOI: 10.19540/j.cnki.cjcmm.20240730.501
[Interpretation of connotation of Yuebi Plus Banxia Decoction based on severe cases and modern pathophysiological mechanisms and experience of treating severe pulmonary infection, acute exacerbation of chronic obstructive pulmonary disease, and respiratory failure with this decoction]
Abstract
Yuebi Plus Banxia Decoction is derived from the Synopsis of the Golden Chamber(Jin Gui Yao Lue) by ZHANG Zhong-jing. With the effects of ventilating lung, discharging heat, descending adverse Qi, and relieving cough and asthma, this prescription is mainly used to treat pulmonary distension caused by phlegm heat obstructing the lungs. Currently, it is commonly used in clinical practice for the treatment of acute exacerbation of chronic obstructive pulmonary disease, acute bronchitis, pneumonia, bronchial asthma, pulmonary heart disease, and pertussis. In the original text, lung distension refers to the inability of lung Qi to descend, including symptoms such as barrel chest, chest tightness, shortness of breath, coughing, and phlegm accumulation, and it is often seen in acute exacerbation of chronic obstructive pulmonary disease. The description of "the patient is panting and their eyes are likely to dislodge" indicates that Yuebi Plus Banxia Decoction is used to treat severe cases of pathogenic heat obstructing the lungs. The description of "the eyes are likely to dislodge" does not refer to hyperthyroidism with sunken orbits, but to the enlarged eye opening caused by severe coughing and asthma as well as chemosis caused by type Ⅱ respiratory failure. The disease indications of this prescription include acute exacerbation of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease combined with type Ⅱ respiratory failure, severe pulmonary infection, pulmonary heart disease combined with infection, interstitial pneumonia, and bronchial asthma. The symptom and sign indications of this prescription include chest tightness, wheezing, cough, expectoration, yellow and sticky phlegm, difficult cough, dry mouth/thirst, desire for cold drinks, irritability, enlarged open of eyes, chemosis, dry stool, yellow urine, red tongue, thin white or yellow tongue coating, dry tongue coating, and floating and slippery powerful pulse. In terms of the disease nature, the indications of this prescription are mainly excess syndromes and rarely include deficiency syndromes. In terms of treatment course, one or two bags of Yuebi Plus Banxia Decoction can demonstrate effects of relieving dyspnea and coughing. In terms of prescription identification, Yuebi Plus Banxia Decoction needs to be distinguished from Yuebi Decoction and Yuebi Plus Atractylodes Macrocephala Decoction. In terms of pharmacological effects, Yuebi Plus Banxia Decoction demonstrates anti-inflammatory and antioxidant effects and can alleviate congestion and edema in the bronchial wall and surrounding interstitium.
Keywords: Synopsis of the Golden Chamber(Jin Gui Yao Lue); Yuebi Plus Banxia Decoction; acute exacerbation of chronic obstructive pulmonary disease; pulmonary infection; respiratory failure; severe and critical cases.
Similar articles
-
[Connotation of Xiao Chaihu Decoction combined with Maxing Shigan Decoction based on severe cases and modern pathophysiological mechanism and application for severe pulmonary infection and acute exacerbation of chronic obstructive pulmonary disease in critical care medicine].Zhongguo Zhong Yao Za Zhi. 2023 May;48(10):2606-2612. doi: 10.19540/j.cnki.cjcmm.20230215.501. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37282920 Chinese.
-
[Connotation of deficiency-induced chest impediment and Renshen Decoction based on severe cases and modern pathophysiological mechanisms and its application in treatment of coronary heart disease, rheumatic heart disease, heart failure, hypotension, pulmonary arterial hypertension, and other critical illnesses].Zhongguo Zhong Yao Za Zhi. 2025 Mar;50(6):1706-1714. doi: 10.19540/j.cnki.cjcmm.20241106.501. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40350958 Review. Chinese.
-
[Zhenwu Decoction:connotation interpretation based on severe cases and modern pathophysiological mechanisms and application in treatment of heart failure in critical care unit].Zhongguo Zhong Yao Za Zhi. 2023 May;48(10):2595-2605. doi: 10.19540/j.cnki.cjcmm.20230310.502. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37282919 Chinese.
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
[Interpretation of connotation of Simiao Yong'an Decoction based on severe cases and modern pathophysiological mechanisms and experience in treating diabetic foot with infection, sepsis, and arteriosclerosis obliterans in critical care medicine].Zhongguo Zhong Yao Za Zhi. 2025 Jan;50(1):267-272. doi: 10.19540/j.cnki.cjcmm.20240924.501. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 39929667 Review. Chinese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical